Teva Atty Says Gilead Deal Followed Bad News On FDA Filing
A top Teva lawyer testified Wednesday in an antitrust trial over claims that the company struck an illegal "pay for delay" deal with Gilead over two HIV medications, saying Teva reached...To view the full article, register now.
Already a subscriber? Click here to view full article